Andros Pharmaceuticals Co.,Ltd (TPEX:6917)
Taiwan
· Delayed Price · Currency is TWD 38.25
-1.85 (-4.61%)
Apr 29, 2026, 1:53 PM CST
TPEX:6917 Market Cap
TPEX:6917 has a market cap or net worth of 1.82 billion as of April 29, 2026. Its market cap has increased by 128.94% in one year.
Market Cap
1.82B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
38.25
Market Cap Chart
Since January 12, 2023, TPEX:6917's market cap has increased from 1.11B to 1.82B, an increase of 63.51%. That is a compound annual growth rate of 16.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.82B | 65.02% |
| Dec 31, 2025 | 1.10B | 43.17% |
| Dec 31, 2024 | 770.08M | -30.92% |
| Dec 29, 2023 | 1.11B | 0.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio Preventive Medicine | 1.69B |
| TaiRx | 1.84B |
| Great Novel Therapeutics Biotech & Medicals | 1.85B |
| Advagene Biopharma | 1.54B |
| GenMont Biotech Incorporation | 1.54B |
| Anti-Microbial Savior BioteQ | 1.98B |
| Synbio Tech | 1.99B |
| Sunny Pharmtech | 2.07B |